Boothbay Fund Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Boothbay Fund Management's RGEN Position: Q2 2026 in Review
Boothbay Fund Management increased its Repligen (RGEN) stake by 27% in Q2 2026, buying an estimated $647K and bringing the position to 24,465 shares worth $3.34M. The position accounts for 0.04% of the portfolio, ranked #490.
Boothbay Fund Management first reported a position in RGEN in Q3 2019 and has held it in 3 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Boothbay Fund Management held 24,465 shares of Repligen worth $3.34M as of Q2 2026.
- Boothbay Fund Management bought 5,267 Repligen shares in Q2 2026, an estimated $647K.
- Repligen made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #490 holding.
- Boothbay Fund Management first reported a position in Repligen in Q3 2019 and has held it in 3 quarters since.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.